News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
795,321 Results
Type
Article (60912)
Company Profile (336)
Press Release (734059)
Multimedia
Podcasts (132)
Webinars (23)
Section
Business (219477)
Career Advice (2912)
Deals (37733)
Drug Delivery (146)
Drug Development (87309)
Employer Resources (185)
FDA (17725)
Job Trends (16391)
News (373465)
Policy (36661)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2969)
Academic (1)
Accelerated approval (39)
Adcomms (35)
Allergies (165)
Alliances (53652)
ALS (193)
Alzheimer's disease (1810)
Antibody-drug conjugate (ADC) (363)
Approvals (17943)
Artificial intelligence (618)
Autoimmune disease (200)
Automation (47)
Bankruptcy (393)
Best Places to Work (12366)
BIOSECURE Act (21)
Biosimilars (206)
Biotechnology (212)
Bladder cancer (175)
Brain cancer (68)
Breast cancer (694)
Cancer (5307)
Cardiovascular disease (464)
Career advice (2469)
Career pathing (44)
CAR-T (309)
CDC (62)
Celiac Disease (2)
Cell therapy (826)
Cervical cancer (41)
Clinical research (74367)
Collaboration (1926)
Company closure (4)
Compensation (1242)
Complete response letters (78)
COVID-19 (2957)
CRISPR (108)
C-suite (972)
Cystic fibrosis (151)
Data (6736)
Decentralized trials (2)
Denatured (42)
Depression (164)
Diabetes (542)
Diagnostics (7190)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (291)
Drug pricing (218)
Drug shortages (33)
Duchenne muscular dystrophy (265)
Earnings (94081)
Editorial (69)
Employer branding (23)
Employer resources (163)
Events (127246)
Executive appointments (1071)
FDA (21079)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1618)
Gene editing (227)
Generative AI (55)
Gene therapy (689)
GLP-1 (1133)
Government (5239)
Grass and pollen (8)
Guidances (388)
Healthcare (20512)
HIV (74)
Huntington's disease (54)
IgA nephropathy (89)
Immunology and inflammation (299)
Immuno-oncology (75)
Indications (137)
Infectious disease (3272)
Inflammatory bowel disease (216)
Inflation Reduction Act (15)
Influenza (131)
Intellectual property (266)
Interviews (561)
IPO (17293)
IRA (58)
Job creations (4369)
Job search strategy (2009)
JPM (67)
Kidney cancer (20)
Labor market (90)
Layoffs (627)
Leadership (43)
Legal (9068)
Liver cancer (102)
Longevity (21)
Lung cancer (715)
Lymphoma (395)
Machine learning (48)
Management (63)
Manufacturing (887)
MASH (185)
Medical device (14949)
Medtech (15016)
Mergers & acquisitions (21555)
Metabolic disorders (1449)
mRNA (192)
Multiple sclerosis (180)
NASH (23)
Neurodegenerative disease (377)
Neuropsychiatric disorders (107)
Neuroscience (3224)
Neurotech (1)
NextGen: Class of 2026 (7274)
Non-profit (4990)
Now hiring (69)
Obesity (701)
Opinion (330)
Ovarian cancer (175)
Pain (231)
Pancreatic cancer (255)
Parkinson's disease (319)
Partnered (34)
Patents (546)
Patient recruitment (562)
Peanut (65)
People (64682)
Pharmaceutical (73)
Pharmacy benefit managers (32)
Phase 1 (23099)
Phase 2 (32547)
Phase 3 (24379)
Pipeline (6257)
Policy (343)
Postmarket research (3020)
Preclinical (9932)
Press Release (72)
Prostate cancer (272)
Psychedelics (60)
Radiopharmaceuticals (312)
Rare diseases (1004)
Real estate (6668)
Recruiting (77)
Regulatory (27319)
Reports (54)
Research institute (2676)
Resumes & cover letters (458)
Rett syndrome (31)
RNA editing (18)
RSV (87)
Schizophrenia (166)
Series A (272)
Series B (204)
Service/supplier (14)
Sickle cell disease (110)
Special edition (26)
Spinal muscular atrophy (173)
Sponsored (45)
Startups (4017)
State (2)
Stomach cancer (21)
Supply chain (118)
Tariffs (95)
The Weekly (88)
Vaccines (1151)
Venture capital (100)
Weight loss (471)
Women's health (105)
Worklife (22)
Date
Today (152)
Last 7 days (724)
Last 30 days (3053)
Last 365 days (31541)
2026 (6014)
2025 (31756)
2024 (36921)
2023 (41934)
2022 (53213)
2021 (57975)
2020 (56903)
2019 (50260)
2018 (38142)
2017 (35037)
2016 (35233)
2015 (41244)
2014 (35299)
2013 (30865)
2012 (32978)
2011 (33539)
2010 (32160)
Location
Africa (974)
Alabama (89)
Alaska (7)
Arizona (336)
Arkansas (15)
Asia (45301)
Australia (8140)
California (12066)
Canada (3456)
China (1226)
Colorado (510)
Connecticut (531)
Delaware (359)
Europe (101281)
Florida (1798)
Georgia (393)
Hawaii (3)
Idaho (67)
Illinois (985)
India (76)
Indiana (556)
Iowa (23)
Japan (466)
Kansas (132)
Kentucky (46)
Louisiana (35)
Maine (73)
Maryland (1492)
Massachusetts (8763)
Michigan (354)
Minnesota (681)
Mississippi (7)
Missouri (144)
Montana (35)
Nebraska (29)
Nevada (134)
New Hampshire (86)
New Jersey (3235)
New Mexico (31)
New York (3186)
North Carolina (1624)
North Dakota (9)
Northern California (5920)
Ohio (359)
Oklahoma (21)
Oregon (45)
Pennsylvania (2427)
Puerto Rico (25)
Rhode Island (51)
South America (1357)
South Carolina (71)
South Dakota (1)
Southern California (4705)
Tennessee (196)
Texas (1883)
United States (43181)
Utah (365)
Vermont (1)
Virginia (288)
Washington D.C. (86)
Washington State (989)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
795,321 Results for "skyline medical formerly known as biodrain medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
AstraZeneca Builds Obesity Pipeline On ‘Medical Aspect,’ Not Aesthetics
In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company’s approach to obesity drug development based on “the medical aspect” of weight loss, including driving down visceral fat.
November 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
March 3, 2026
·
1 min read
Metabolic disorders
Ascendis Skids as FDA Detects Death in Patient Formerly on Yorvipath
The death occurred in a patient who had a complex medical background and who was being managed with several drugs, according to RBC Capital.
October 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vivani Medical, Inc. Announces Closing of Common Stock Offering
January 28, 2026
·
5 min read
Press Releases
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
·
28 min read
Press Releases
Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors
February 26, 2026
·
8 min read
Press Releases
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
March 20, 2025
·
4 min read
Press Releases
Applied Medical Technology, Inc. Announces U.S. Launch of Explant Express® Breast Implant Suction Retrieval Device for Ruptured Implant Removal
February 26, 2026
·
2 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Press Releases
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
March 4, 2026
·
4 min read
1 of 79,533
Next
